Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ORGENESIS INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
01.05.2026 19:55
Current Prices from ORGENESIS INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
ORGS
USD
01.05.2026 19:55
0,40 USD
0,00 USD
NASDAQ
ORGS
USD
01.05.2026 19:55
0,40 USD
0,00 USD
Share Float & Liquidity
Free Float66,78 %
Shares Float3,45 M
Shares Outstanding5,17 M
Company Profile for ORGENESIS INC Share
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
